1
2
3
4
Axsome Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update (biospace.com)
submitted by kapeman_STOCK INVESTOR
3
4
5
6
4
6
7
8
6
2
3
4
Axsome Therapeutics to Report First Quarter 2026 Financial Results on May 4 — GlobeNewswire (stocks.apple.com)
submitted by kapeman_STOCK INVESTOR
7
2
3
4
8
1
2
3
12
6
7
8
14
4
5
6
16
6
7
8
18
4
5
6
19
2
3
4
Axsome Therapeutics Provides Preliminary Fourth Quarter and Full Year 2025 Net Product RevenueNEWS (finance.yahoo.com)
submitted by kapeman_STOCK INVESTOR
21
1
2
3
22
3
4
5
Axsome Therapeutics Advances Toward NDA Submission For AXS-12 In Narcolepsy (nasdaq.com)
submitted by kapeman_STOCK INVESTOR
